Search Results - "preeclampsia"

Refine Results
  1. 1

    ¿Se puede prevenir la preeclampsia? by Celeste Muntaner

    Published 2024-10-01

    La preeclampsia es una enfermedad multisistémica, exclusiva del ser humano, que afecta del 2-4% de la totalidad de los embarazos. En 2022, en Argentina fue la principal causa de muerte materna. Las estrategias de prevención de la preeclampsia más efectivas incluyen la administración de aspirina, la...

    Full description

    Subjects: “…preeclampsia…”
    Get full text
    Article
  2. 2

    Increased platelet activation and thrombo-inflammation in early and late-onset preeclampsia by Kunal Singh, Massimiliano Lia, Akshay Prakasan Sheeja, Martin Federbusch, Anubhuti Gupta, Ahmed Elwakiel, Moritz Köhler, Berend Isermann, Holger Stepan, Shrey Kohli

    Published 2025-07-01

    Background: Preeclampsia is a vascular complication of pregnancy with limited therapeutic options. It is associated with hypertension and an increase in angiogenic factor soluble fms-like tyrosine kinase-1 (sFlt-1)/placental growth factor. Based on its onset, preclampsia can be categorized into earl...

    Full description

    Subjects: Get full text
    Article
  3. 3

    Metalloproteinases as biochemical markers of pregnancy pathology by K. N. Grigorieva, V. O. Bitsadze, J. Kh. Khizroeva, M. V. Tretyakova, D. V. Blinov, N. A. Makatsariya, V. I. Tsibizova, I. A. Nakaidze, N. R. Gashimova, E. Grandone, A. D. Makatsariya

    Published 2022-03-01

    The success in modern biology has significantly enriched scientific understanding of the pathogenetic basis underlying some diseases, including obstetric and gynecological practice. Despite this, the etiology and pathogenesis of some conditions are not yet fully elucidated. One of the approaches is...

    Full description

    Subjects: Get full text
    Article
  4. 4

    Maternal and Perinatal Outcomes of Early and Late Onset Preeclampsia with Severe Features in Secondary Health Care by Aryani Aziz, Uqbah Abdul Salam

    Published 2025-01-01

    Background: Preeclampsia is a condition characterized by new-onset hypertension during pregnancy, which can lead to various complications for both the mother and baby. It is categorized into early-onset preeclampsia (EO-PE) and late-onset preeclampsia (LO-PE) based on the timing of onset, each havin...

    Full description

    Subjects: “…early-onset preeclampsia…”
    Get full text
    Article
  5. 5

    METHODS TO PREDICT SEVERE FORMS OF PREECLAMPSIA DURING EARLY PREGNANCY by E. I. Sarkisova, A. V. Orlov

    Published 2013-12-01

    Due to the fact that preeclampsia remains one of the difficult issues in obstetrics and is one of the main reasons of maternal and perinatal morbidity and mortality all over the world, the data of late years about the possibility to predict this complication is summarized in the review. The authors...

    Full description

    Subjects: “…preeclampsia…”
    Get full text
    Article
  6. 6

    INFLUENCE OF SOLUBLE PLACENTADERIVED FACTORS UPON EXPRESSION OF SURFACE RECEPTORS ON THP-1 CELLS by T. Yu. Lvova, Ya. S. Onochina, D. A. Korenkov, O. I. Stepanova, K. N. Furaeva, E. A. Potolicina, S. A. Selkov, D. I. Sokolov

    Published 2014-07-01

    Abstract. During the passage through the utero-placental circulation, peripheral blood monocytes are exposed to action of various soluble placenta-derived factors. Subsequently these cells migrate to placental tissue and play a key role in regulation of placental growth and development. We investiga...

    Full description

    Subjects: Get full text
    Article
  7. 7

    Hypertension in pregnancy: controversial issues of national and international guidelines by V. S. Chulkov, A. I. Martynov, V. A. Kokorin

    Published 2021-01-01

    Hypertensive disorders of pregnancy, including pre-existing and gestational hypertension, preeclampsia and eclampsia, complicate up to 10% of pregnancies and represent a significant cause of maternal and perinatal morbidity and mortality. Despite some differences in guidelines, there is consensus th...

    Full description

    Subjects: Get full text
    Article
  8. 8

    Evaluation the levels of Plasma Interleukins (IL-8, IFN-?, IL-10) in Preeclamptic Pregnancies by Baghdad Science Journal

    Published 2011-12-01

    This study is to evaluate plasma levels of several cytokines in preeclamptic pregnancies compared to those of healthy pregnancies. Ninety pregnant women with preeclampsia (37 mild & 53 severe) and thirty healthy pregnant women were enrolled in the study. Blood samples were taken and plasma level...

    Full description

    Subjects: “…preeclampsia, immune response, cytokines…”
    Get full text
    Article
  9. 9

    PREGNANCY AND DELIVERY IN WOMEN WITH A HISTORY OF PREECLAMPSIA HYPERHOMOCYSTEINEMIA TREATED WITH BEMIPARIN IN COMBINATION WITH LOW-DOSE ASPIRIN by L. O. Buzyan, G. G. Buzyan, V. F. Dolgushina

    Published 2016-06-01

    Preeclampsia is a serious complication of pregnancy and one of the leading causes of maternal mortality. According to modern concepts, the key link in the pathogenesis of preeclampsia is an endothelial dysfunction leadind to persistent prothrombotic hemostasis state. Markers and predictors of preecl...

    Full description

    Subjects: Get full text
    Article
  10. 10

    Maternal serum Alpha-fetoprotein Level at 12, 22 and 32weeks’ gestation in screening for pre-eclampsia by Arwa M. Ahmed, Israa' H. Abid Al-Kareem

    Published 2018-08-01

    Pre-eclampsia is a major cause of maternal and perinatal morbidity and mortality. Alpha_fetoprotein is measured in pregnant women, as a screening test for  pre-eclampsia.This study aimed to examine  the maternal serum alpha-fetoprotein at 12, 22 and 32 weeks ’gestation in singleton pregnancies and...

    Full description

    Subjects: “…preeclampsia…”
    Get full text
    Article
  11. 11

    JUSTIFICATION OF CONTROL OF RECEVALESCENCE AND INDIVIDUAL REHABILITATION IN WOMEN WHO UNDERWENT SEVERE PREECLAMPSIA by V. A. NOVIKOVA, Z. S. YUSUPOVA, O. A. SHAPOVALOVA, V. A. KHOROLSKY

    Published 2018-07-01

    Aim. Justification of control of reconvalescence and individual rehabilitation in women who underwent severe preeclampsia (PE). Materials and methods. A prospective, non-randomized, controlled, open-label, nosocomial study was conducted in the period of 2016-2017. 170 women participated: 100 women w...

    Full description

    Subjects: “…severe preeclampsia…”
    Get full text
    Article
  12. 12

    A Changepoint Detection-Based General Methodology for Robust Signal Processing: An Application to Understand Preeclampsia’s Mechanisms by Patricio Cumsille, Felipe Troncoso, Hermes Sandoval, Jesenia Acurio, Carlos Escudero

    Published 2025-06-01

    Motivated by illuminating the underlying mechanisms of preeclampsia, we develop a changepoint detection-based general and versatile methodology that can be applied to any experimental model, effectively addressing the challenges of high uncertainty produced by experimental interventions, intrinsic h...

    Full description

    Subjects: Get full text
    Article
  13. 13

    EFFECTS OF SECRETABLE PLACENTAL FACTORS UPON SECRETION OF CYTOKINES BY THP-1 MONOCYTE-LIKE CELLS by Ya. S. Onokhina, T. Yu. Lvova, D. Z. Tzitzkarava, S. A. Selkov, D. I. Sokolov

    Published 2014-07-01

    Abstract. Мonocytes in feto-placental circulation are exposed to factors secreted by placental tissue. These factors influence monocyte functions in pregnancy. In present study, an in vitro model (monocyte-like THP-1 cells) was used for assessing effects of soluble placental factors obtained from wo...

    Full description

    Subjects: Get full text
    Article
  14. 14

    REALITIES AND PROSPECTS FOR PHARMACOLOGICAL CORRECTION OF «ADMA-ENOS"-ASSOCIATED WAYS IN PREECLAMPSIA by M. V. Pokrovsky, N. G. Filipenko, M. V. Korokin, V. V. Gureyev, T. G. Pokrovsky, A. A. Barsuk, L. V. Korokina, E. V. Proskuryakova, N. V. Maltseva, O. V. Levashova, O. S. Gudyrev, A. S. Belous, O. S. Polyanskaya

    Published 2016-01-01

    Methylated analogs of L-arginine - asymmetric dimetilarginin (ADMA) and monometilarginin (L-NMMA) - are endogenous inhibitors of endothelial NO-synthase (eNOS). ADMA level in maternal plasma is increased in women with preeclampsia. The high level of ADMA is one of the predictors of preeclampsia. L-a...

    Full description

    Subjects: Get full text
    Article
  15. 15

    Exposure to Fine Particulate Matter (PM2.5) and Heavy Metals During the Second Trimester of Pregnancy Increases the Risk of Preeclampsia and Eclampsia: An Analysis of National Heal... by Kuen Su Lee, Won Kee Min, Yoon Ji Choi, Jeongun Cho, Sang Hun Kim, Hye Won Shin

    Published 2025-06-01

    <i>Background and Objectives</i>: Air pollutants have been shown to affect hypertensive disorders and placental hypoxia due to vasoconstriction, inflammation, and oxidative stress. The objective of this study was to evaluate whether high levels of maternal exposure to heavy metals during...

    Full description

    Subjects: Get full text
    Article
  16. 16

    ANTITHROMBOTIC PROPHYLAXIS RECURRENT PREECLAMPSIA IN PATIENTS WITH THROMBOPHILIA by E. V. Zhuravleva, V. O. Bitsadze, A. D. Makatsariya

    Published 2016-06-01

    Objective. To evaluate the efficiency of antithrombotic therapy to prevent repeated preeclampsia in patients with thrombophilia. Subject and methods. A prospective clinical study was conducted 66 patients with thrombophilia (genetic, acquired or concomitant) and with history of preeclampsia: 35 pati...

    Full description

    Subjects: “…preeclampsia…”
    Get full text
    Article
  17. 17

    ANTITHROMBOTIC PROPHYLAXIS REPEATED PREECLAMPSIA IN PATIENTS WITH THROMBOPHILIA by E. V. Zhuravleva

    Published 2016-06-01

    Objective. To evaluate the efficiency of antithrombotic therapy to prevent repeated preeclampsia in patients with thrombophilia. Subject and methods. A prospective clinical study was conducted 66 patients with thrombophilia (genetic, acquired or concomitant) and with history of preeclampsia: 35 pati...

    Full description

    Subjects: “…preeclampsia…”
    Get full text
    Article
  18. 18

    Evaluation of Key Indicators for Assessing and Grading Severity of Preeclampsia by Radhia A. Alshihabi, Yasmin L. Al-Saadi

    Published 2025-07-01

    Background: Preeclampsia (PE) is a condition that is specific to pregnancy and has a substantial impact on the morbidity and mortality of the mother and the fetus worldwide. Currently, various markers may serve as possible predictors or markers for illness severity. Objectives: The present study...

    Full description

    Subjects: Get full text
    Article
  19. 19

    Relationship between Elevated Maternal Serum Podocalyxin Concentrations with Blood Pressure Values and Routine Laboratory Parameters in Preeclampsia by Nikola Popovski, Asparuh Nikolov, Yordan Popov, Svetla Blazheva

    Published 2021-12-01

    Podocalyxin (PCX) is a glycoprotein member of the CD34 transmembrane sialomucin family and covers the surface of podocytes. It is assumed to be a marker of glomerular endothelial injury. In conditions, podocalyxin excretion in the urine is increased as a result of podocyte injury. Recent studies sho...

    Full description

    Subjects: Get full text
    Article
  20. 20

    Examining the relationship between maternal preeclampsia and autism spectrum disorder in childhood by Noam Shema, Omri Zamstein, Tamar Wainstock, Gali Pariente, Eyal Sheiner

    Published 2025-12-01

    Objective Autism spectrum disorder (ASD) has multifactorial origins, some related to the prenatal period. Preeclampsia, a serious pregnancy complication, is also multifactorial. This study aimed to explore the potential association between preeclampsia and ASD in a diverse population.Study Design A...

    Full description

    Subjects: “…Preeclampsia…”
    Get full text
    Article